CytoDyn Inc. (CYDY: OTCQB) | CytoDyn to Amend Protocol for PRO 140 Phase 2 Trial in GvHD

Source: OTC Markets

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>